{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:30Z","timestamp":1790946690534,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bcmd.2015.05.009","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T04:43:00Z","timestamp":1432701780000},"page":"134-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology"],"prefix":"10.1016","volume":"55","author":[{"given":"J.M.","family":"Mucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Cuello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kisinovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Larroude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Delpino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-0468","authenticated-orcid":false,"given":"P.A.","family":"Rozenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2015.05.009_bb0005","series-title":"The Online Metabolic and Molecular Basis of Inherited Disease","article-title":"Gaucher disease","author":"Grabowski","year":"2009"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","article-title":"Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy","volume":"90","author":"Deegan","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ymgme.2011.08.004","article-title":"Therapeutic approaches to bone pathology in Gaucher disease: past, present and future","volume":"104","author":"Goker-Alpan","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0020","first-page":"299","article-title":"Gaucher disease: clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1196\/annals.1443.016","article-title":"RANK\/RANKL: regulators of immune responses and bone physiology","volume":"1143","author":"Leibbrandt","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2008.02.017","article-title":"Estrogen deficiency increases osteoclastogenesis upregulating T cells activity: a key mechanism in osteoporosis","volume":"43","author":"D'Amelio","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0040","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","article-title":"Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts","volume":"275","author":"Azuma","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0045","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/endo.143.3.8701","article-title":"TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL","volume":"143","author":"Fuller","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0050","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4419-1050-9_7","article-title":"The unexpected link between osteoclasts and the immune system","volume":"658","author":"Takayanagi","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","article-title":"The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models","volume":"7","author":"Lubberts","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0065","doi-asserted-by":"crossref","first-page":"720504","DOI":"10.1155\/2013\/720504","article-title":"The interplay between the bone and the immune system","volume":"2013","author":"Mori","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10875-009-9345-1","article-title":"Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease","volume":"30","author":"Eastaff-Leung","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0075","doi-asserted-by":"crossref","first-page":"e14167","DOI":"10.1371\/journal.pone.0014167","article-title":"Bone impairment in phenylketonuria is characterized by circulating osteoclasts precursors and activated T cell increase","volume":"5","author":"Roato","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12018-009-9057-3","article-title":"Osteoclast formation from peripheral blood of patients with bonelytic diseases","volume":"7","author":"de Vries","year":"2009","journal-title":"Clin. Rev. Bone Miner. Metab."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00774-008-0011-0","article-title":"Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients","volume":"27","author":"Nose","year":"2009","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1600-051X.2008.01241.x","article-title":"Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor","volume":"35","author":"Tjoa","year":"2008","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gene.2012.07.071","article-title":"Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-\u03b1","volume":"509","author":"Mucci","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcmd.2013.04.006","article-title":"Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease","volume":"51","author":"Reed","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2013.09.072","article-title":"Uncoupling of osteoblast\u2013osteoclast regulation in a chemical murine model of Gaucher disease","volume":"532","author":"Mucci","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0105","first-page":"205","article-title":"Cytokines in Gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0115","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/er.2007-0038","article-title":"Osteoimmunology: interactions of the bone and immune system","volume":"29","author":"Lorenzo","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0125","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20101474","article-title":"Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo","volume":"207","author":"Ishii","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0130","doi-asserted-by":"crossref","first-page":"e3627","DOI":"10.1371\/journal.pone.0003627","article-title":"Osteoclasts are active in bone forming metastases of prostate cancer patients","volume":"3","author":"Roato","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2015.05.009_bb0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.33418","article-title":"The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population","volume":"64","author":"Rossol","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0140","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0145","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.23138","article-title":"Treg cells suppress osteoclast formation: a new link between the immune system and bone","volume":"56","author":"Zaiss","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00774-003-0439-1","article-title":"The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis","volume":"21","author":"Udagawa","year":"2003","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/path.2153","article-title":"Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis","volume":"212","author":"Colucci","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0160","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar2915","article-title":"CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis","volume":"12","author":"Chiu","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL\u2013RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/s10165-011-0530-8","article-title":"Regulation of osteoclast function","volume":"22","author":"Nakamura","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0180","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcmd.2011.04.005","article-title":"Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction","volume":"47","author":"Elstein","year":"2011","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcmd.2014.02.006","article-title":"Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up","volume":"53","author":"Elstein","year":"2014","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0195","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.clinthera.2007.08.006","article-title":"Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies","volume":"29","author":"Pastores","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bcmd.2015.05.009_bb0200","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00256-014-1891-9","article-title":"Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat","volume":"43","author":"Kamath","year":"2014","journal-title":"Skelet. Radiol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:31:09Z","timestamp":1761049869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979615000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1079979615000972"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.05.009","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}